Biologic Therapies Targeting Eosinophilic Gastrointestinal Diseases-Reference-Cited by-同舟云学术

Biologic Therapies Targeting Eosinophilic Gastrointestinal Diseases

Published:2023-12-01 Issue:23 Volume:62 Page:3429-3430
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Oshima Tadayuki¹

Affiliation:

1. Department of Gastroenterology and Hepatology, Hyogo Medical University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/62/23/62_1911-23/_pdf

Reference7 articles.

1. 1. Dellon ES, Gonsalves N, Abonia JP, et al. International consensus recommendations for eosinophilic gastrointestinal disease nomenclature. Clin Gastroenterol Hepatol 20: 2474-2484.e2473, 2022.

2. 2. Ito K, Shibuya T, Nomura K, et al. Successful treatment of steroid-resistant eosinophilic gastrointestinal disease with mepolizumab. Intern Med 62: 3461-3467, 2023.

3. 3. Lucendo AJ, Arias A, Molina-Infante J. Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 14: 13-22.e11, 2016.

4. 4. Lipka S, Kumar A, Miladinovic B, Richter JE. Systematic review with network meta-analysis: comparative effectiveness of topical steroids vs. PPIs for the treatment of the spectrum of eosinophilic oesophagitis. Aliment Pharmacol Ther 43: 663-673, 2016.

5. 5. Pitlick MM, Li JT, Pongdee T. Current and emerging biologic therapies targeting eosinophilic disorders. World Allergy Organ J 15: 100676, 2022.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional Dyspepsia: Current Understanding and Future Perspective;Digestion;2023-08-18